Skip to content
Site Tools
Narrow screen resolution Wide screen resolution Auto-adjust screen resolution Increase font size Decrease font size Default font size
You are here: Home arrow Latest News
Latest News
Drug development PDF Print E-mail
User Rating: / 3
Written by bioXplorer   
  • New Pennsylvania law to permit RPh-MD collaborations
    Collaborative practice agreements between physicians and pharmacists will be a reality in Pennsylvania within the next couple of years. (Source: Drug Topics - Pharmacy News)

    MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.



  • Washington State pharmacy board reconsiders Plan B
    The Washington State Board of Pharmacy is revisiting its rules requiring pharmacists to dispense emergency contraceptives. (Source: Drug Topics - Pharmacy News)

  • Controlled substance dilemma
    Community pharmacists face a different "War on Drugs" than the one heard about on the news. This war doesn't even seem to be on lawmakers' radar. (Source: Drug Topics - Pharmacy News)

  • Plavix biomarker test can improve patient outcomes
    In a novel collaboration with PBM giant CVS Caremark and its specialty pharmacy Generation Health, PGXL Laboratories will use its expertise in anticoagulants to improve the quality of patient care through pharmacogenetic testing, physician education, and drug-specific software programs. (Source: Drug Topics - Pharmacy News)

  • FDA continues scrutiny of DTC genetic tests
    Underlying a recent FDA-hosted public meeting and workshop was the question of how FDA as a regulatory agency should increase its current oversight of clinical laboratories, specifically those developing genetic tests that may be offered at their own facilities or made available through direct-to-consumer channels. (Source: Drug Topics - Pharmacy News)

  • Local pharmacists: Serving their communities
    Patients often bring their own set of challenges with them to the pharmacy counter and community pharmacists have taken notice. Many have responded by creating programs that not only help patients secure the medication they need, but also offer them ways to make the most of their treatment plans. (Source: Drug Topics - Pharmacy News)

    MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.



  • FDA panel rejects REMS proposal for long-acting opioids
    FDA advisory committee members voted 25 to 10 to reject a proposed plan to establish a risk evaluation and mitigation strategy for extended-release and long-acting opioid analgesics during the joint meeting on July 23 of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee in Adelphi, Md. (Source: Drug Topics - Pharmacy News)

  • Monitoring controlled substances
    Thirty-nine states now have a tool to help pharmacists identify at least some questionable prescriptions and suggest when a patient may be doctor-shopping or pharmacy-shopping in order to obtain controlled substances. That tool is the state prescription monitoring program. (Source: Drug Topics - Pharmacy News)

  • PDMP bill supports state information exchange
    A Congressional bill aims to boost the capacity for information exchange among state programs that monitor prescription controlled substances and seeks to provide continued grant funding to support such efforts. (Source: Drug Topics - Pharmacy News)

  • Pediatric medication recall: Generics, house brands fill void
    Generic manufacturers and consumer budgets are the big winners in the ongoing voluntary recall of millions of packages of pediatric liquid medications manufactured by McNeil Consumer Healthcare. (Source: Drug Topics - Pharmacy News)

<< Start < Previous 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 5 - 5 of 10